Literature DB >> 17932487

Interaction of tau protein with the dynactin complex.

Enrico Magnani1, Juan Fan, Laura Gasparini, Matthew Golding, Meredith Williams, Giampietro Schiavo, Michel Goedert, Linda A Amos, Maria Grazia Spillantini.   

Abstract

Tau is an axonal microtubule-associated protein involved in microtubule assembly and stabilization. Mutations in Tau cause frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), and tau aggregates are present in Alzheimer's disease and other tauopathies. The mechanisms leading from tau dysfunction to neurodegeneration are still debated. The dynein-activator complex dynactin has an essential role in axonal transport and mutations in its gene are associated with lower motor neuron disease. We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. Tau and dynactin show extensive colocalization, and the attachment of the dynactin complex to microtubules is enhanced by tau. Mutations of a conserved arginine residue in the N-terminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain. These findings, which suggest a direct involvement of tau in axonal transport, have implications for understanding the pathogenesis of tauopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932487      PMCID: PMC2063488          DOI: 10.1038/sj.emboj.7601878

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  39 in total

1.  Evidence for two distinct binding sites for tau on microtubules.

Authors:  Victoria Makrides; Michelle R Massie; Stuart C Feinstein; John Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

Review 2.  Dynactin.

Authors:  Trina A Schroer
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

3.  Mutant dynactin in motor neuron disease.

Authors:  Imke Puls; Catherine Jonnakuty; Bernadette H LaMonte; Erika L F Holzbaur; Mariko Tokito; Eric Mann; Mary Kay Floeter; Kimberly Bidus; Dennis Drayna; Shin J Oh; Robert H Brown; Christy L Ludlow; Kenneth H Fischbeck
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

4.  Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly.

Authors:  M Hasegawa; M J Smith; M Goedert
Journal:  FEBS Lett       Date:  1998-10-23       Impact factor: 4.124

5.  Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.

Authors:  Bin Zhang; Makoto Higuchi; Yasumasa Yoshiyama; Takeshi Ishihara; Mark S Forman; Dan Martinez; Sonali Joyce; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2004-05-12       Impact factor: 6.167

Review 6.  Motor neurons rely on motor proteins.

Authors:  Erika L F Holzbaur
Journal:  Trends Cell Biol       Date:  2004-05       Impact factor: 20.808

7.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

8.  Tau proteins: the molecular structure and mode of binding on microtubules.

Authors:  N Hirokawa; Y Shiomura; S Okabe
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

Review 9.  Tau protein in familial and sporadic diseases.

Authors:  Despina Yancopoulou; Maria Grazia Spillantini
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

10.  Conformational changes in CLIP-170 regulate its binding to microtubules and dynactin localization.

Authors:  Gideon Lansbergen; Yulia Komarova; Mauro Modesti; Claire Wyman; Casper C Hoogenraad; Holly V Goodson; Régis P Lemaitre; David N Drechsel; Erik van Munster; Theodorus W J Gadella; Frank Grosveld; Niels Galjart; Gary G Borisy; Anna Akhmanova
Journal:  J Cell Biol       Date:  2004-09-20       Impact factor: 10.539

View more
  78 in total

Review 1.  Tau-targeted treatment strategies in Alzheimer's disease.

Authors:  Jürgen Götz; Arne Ittner; Lars M Ittner
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

3.  Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions.

Authors:  Zdena Kristofikova; Daniela Ripova; Katerina Hegnerová; Jana Sirova; Jiri Homola
Journal:  Neurochem Res       Date:  2013-07-04       Impact factor: 3.996

Review 4.  Murine models of Alzheimer's disease and their use in developing immunotherapies.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Biochim Biophys Acta       Date:  2010-05-13

5.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

Review 6.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

7.  Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.

Authors:  Chris D Pacheco; Matthew J Elrick; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

Review 8.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

Review 9.  Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

Authors:  Thomas Wisniewski; Allal Boutajangout
Journal:  Brain Struct Funct       Date:  2009-12-10       Impact factor: 3.270

10.  A new link to mitochondrial impairment in tauopathies.

Authors:  Kathrin L Schulz; Anne Eckert; Virginie Rhein; Sören Mai; Winfried Haase; Andreas S Reichert; Marina Jendrach; Walter E Müller; Kristina Leuner
Journal:  Mol Neurobiol       Date:  2012-07-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.